FindTrial
Sign In

Management of Endometriosis in Unani compound medicine specially pain in Endometriosis

A Pilot Study On The Efficacy Of Unani Management In Endometriosis (Batan-E-Rehmiyat) With Chronic Pelvic Pain And Dysmenorrhea. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106744
Enrollment
6
Registered
2026-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N719- Inflammatory disease of uterus, unspecified

Interventions

Intervention1: Majoon Dabeedulward and Arqe Brinjasif: Majoon Dabeedulward 10 gm twice a day with arqe brinjasif 20ml twice daily for 3 months Control Intervention1: not applicable: not applicable

Sponsors

A and U Tibbia college and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women aged 18â??45 years,Diagnosed cases of endometriosis confirmed by USG or MRI,Complaints of dysmenorrhea and/or chronic pelvic pain,No hormonal or surgical treatment for endometriosis in the last three months,Willingness to participate and provide informed consent.

Exclusion criteria

Exclusion criteria: patient fails to follow instructions

Design outcomes

Primary

MeasureTime frame
1. Pain Assessment â?? Visual Analogue Scale (VAS) 2. Dysmenorrhea Severity Score 3. Menstrual Parameters 4. Quality of Life Assessment Timepoint: base line , 15 days,30 days , 45 days and 60 days—

Secondary

MeasureTime frame
not applicableTimepoint:—

Countries

India

Contacts

Public ContactDr Abdul Nasir

A and U Tibbia college and Hospital

a.nasir.119@gmail.com9354925039

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026